Skip to main content
B

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 718 across all filing types
Latest filing 2026-04-28 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
百济神州有限公司2026年年度股东大会会议资料
Regulatory Filings
2026-04-28 Chinese
百济神州有限公司关于2026年年度股东大会股权登记日的公告
Regulatory Filings Classification · 1% confidence The document is a formal announcement of the share‐ownership record date for the 2026 Annual General Meeting rather than the AGM materials themselves, an earnings report, or any other specific filing type. It does not contain voting results, executive compensation detail, financial statements, or a request for proxy votes. It also does not present any substantive report but merely notifies shareholders of the record date. Therefore it falls into the general “Regulatory Filings (RNS)” category as a miscellaneous regulatory announcement.
2026-04-28 Chinese
百济神州有限公司关于召开2026年年度股东大会的通知
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a detailed notice to convene the 2026 annual general meeting, providing the meeting agenda, proposals to be voted on, voting and proxy procedures, and including a proxy authorization form. This matches a proxy solicitation/information statement (materials sent to shareholders to request votes and provide meeting information). Therefore, it falls under Proxy Solicitation & Information Statement (Code: PSI).
2026-04-28 Chinese
百济神州有限公司关于签订合作协议暨关联交易的公告
Regulatory Filings Classification · 1% confidence The document is a corporate announcement in Chinese regarding the signing of a cooperation agreement and details of a related‐party transaction (关联交易). It cites Shanghai Stock Exchange disclosure rules and describes the transaction structure, pricing, and board approval. It is not an annual, interim, or earnings report, nor is it a dividend, financing, M&A, or board change announcement. It is a general regulatory disclosure of a related‐party deal, so it falls under the catch‐all Regulatory Filings category (RNS).
2026-04-27 Chinese
港股公告：2026年第一季度财务业绩公布日期及审计委员会行动通告
Report Publication Announcement Classification · 1% confidence The document is an announcement titled “2026年第一季度财务业绩公布日期及审计委员会行动通告,” which informs investors of the date (May 6, 2026) for the release of Q1 2026 unaudited financial results and related audit committee review, and provides details about a subsequent conference call and webcast. It contains no actual financial data or report content, only the timing and logistics of the forthcoming results publication. This fits the definition of a Report Publication Announcement (RPA), which covers announcements regarding the timing or release of company reports.
2026-04-22 Chinese
百济神州有限公司自愿披露关于公司举行业绩电话会议的公告
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 600 characters) informing investors that the company will release its Q1 2026 financial results and hold a performance telephone conference on a specified date/time, with a webcast link. It does not contain the actual financial data or results, nor a transcript. Under the “menu vs meal” rule, this is not the report itself but a notification of its upcoming publication and conference, fitting the definition of a Report Publication Announcement (RPA).
2026-04-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.